Latest Security News

H2G Limited trims its half-year loss by a third while advancing sodium-ion battery production and securing a $4.5 million sales pipeline. Strategic partnerships and government certification efforts aim to boost market adoption.

Loyal Metals (ASX:LLM) schedules a key court hearing on 24 August to approve PT Bumi Resources’ A$79 million takeover scheme, with most conditions including shareholder approval and project acquisitions progressing smoothly.

Audalia Resources has raised $450,000 through a placement of 15 million shares at 3 cents each, aiming to push the Medcalf project towards production while maintaining working capital.

Energy Fuels Inc. reported a transformative 2024 with a major acquisition boosting its heavy mineral sands assets, a uranium production ramp-up at key US mines, and commercial rare earth oxide output from its White Mesa Mill.

SCX.ai Holdings Limited is set to raise $40 million through a fully underwritten IPO at $0.30 per share, aiming to scale its sovereign AI inferencing platform built on ASIC hardware within Australian data centres. The company targets the fast-growing AI IaaS market with a focus on secure, low-latency AI workloads.

Australis Oil & Gas Ltd posted a $2.6 million net loss for 1H 2026 amid sharply reduced production volumes but is progressing its Tuscaloosa Marine Shale development with a key partner and a planned Q4 well spud.

Synertec Corporation has been awarded the delivery phase of the Brooklyn Pump Station IO Upgrade by Melbourne Water, extending a contract valued at approximately $1.1 million. The project modernises critical water infrastructure with advanced operational technology.

Ironbark Balanced Income Limited reported a 5.6% decline in net profit to $2.89 million for FY2026, while its investment portfolio delivered a solid 7.8% return, outperforming its benchmark and maintaining fully franked dividends.

Energy Fuels’ acquisition of Australian Strategic Materials (ASM) has officially closed following Federal Court approval, triggering suspension of ASM trading and setting the stage for shareholder payments and new listings.

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.

Recce Pharmaceuticals has secured ethics approval to add an active-controlled arm to its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, enabling head-to-head comparison against existing antibiotics.

Seeka Ltd (NZX:SEK) has announced a fully imputed dividend of 20 cents per share, payable in October, alongside a reinstatement of its biannual dividend schedule. The dividend reinvestment plan offers a 2% discount on shares acquired via the plan.